Publications
- Aggressive acute myeloid leukemia in PU.1/p53 double-mutant mice2014 | First Faculty of Medicine
- Analysis of 5-Azacytidine Resistance Models Reveals a Set of Targetable Pathways2022 | First Faculty of Medicine
- Hereditary Haemorrhagic Telangiectasia (HHT) Marked by ACVRL1(C1120T) Variant Displays Hypopigmented Naevi and Frequent Bleeding Episodes if CYP2C9 Co-Mutated: Clinical Notes & Rationale of Patient Registry2020 | First Faculty of Medicine
- Manipulation of spermatogonial stem cells in livestock species2019 | First Faculty of Medicine
- MiR-155/miR-150 network regulates progression through the disease phases of chronic lymphocytic leukemia2017 | First Faculty of Medicine, Faculty of Mathematics and Physics
- Modeling cancer driver events in vitro using barrier bypass-clonal expansion assays and massively parallel sequencing2017 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Somatic mutation dynamics in MDS patients treated with azacitidine indicate clonal selection in patients-responders2017 | First Faculty of Medicine, Faculty of Mathematics and Physics
- Differential expression, localization and activity of MARCKS between mantle cell lymphoma and chronic lymphocytic leukemia2016 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Oncogenic microRNA-155 and its target PU.1: an integrative gene expression study in six of the most prevalent lymphomas2015 | First Faculty of Medicine
- 5-Azacitidine in aggressive myelodysplastic syndromes regulates chromatin structure at PU.1 gene and cell differentiation capacity2012 | First Faculty of Medicine
Loading network view...